Model
Edge
Ultragenyx Pharmaceutical Inc.
0001603347
Filing Type
4
Filing Date
9/17/2024
Updated
9/18/24, 11:03 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership